Progress of myeloid-derived suppressor cells in hematological tumors / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 698-701, 2020.
Article
em Zh
| WPRIM
| ID: wpr-862907
Biblioteca responsável:
WPRO
ABSTRACT
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature myeloid cells that can regulate the immune response. They play an important role in the formation and progression of tumors and can suppress immune response in infections and inflammatory diseases. In recent years, MDSC have attracted a lot of attention in the field of tumor immunology, especially in solid tumors, but little is known about the role in hematological tumors. In this paper, the characteristics, functions and related clinical researches of MDSC in hematological tumors including multiple myeloma (MM), lymphoma, leukemia, and myelodysplastic syndrome (MDS) will be summarized to provide new ideas for the treatment of hematologic system tumors.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Revista:
Journal of Leukemia & Lymphoma
Ano de publicação:
2020
Tipo de documento:
Article